Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
12–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and/or female subjects 12 to \< 18 years of age at the time of randomization
Male and/or female subjects between 18 and 50 years of age (inclusive) at the time of randomization
Body weight ≥ 36 kg at screening
Intermittent or mild to moderate persistent asthma for at least the past 3 months prior to study enrollment (as defined by the 2004 Global Initiative for Asthma \[GINA\] guidelines.
You may not be if
Experienced an asthma exacerbation (defined as a disease episode resulting in treatment in an emergency room or urgent care facility, or an episode treated with oral corticosteroids) during the 3 months prior to study enrollment.
Hospitalized for asthma during the 6 months prior to study enrollment; or ever intubated for the treatment of asthma.
Use of oral corticosteroids within 3 months prior to study enrollment.
Clareo Health | Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma
